BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30409252)

  • 1. Functional MRI in Atypical Parkinsonisms.
    Agosta F; Sarasso E; Filippi M
    Int Rev Neurobiol; 2018; 142():149-173. PubMed ID: 30409252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECT Molecular Imaging in Atypical Parkinsonism.
    Brumberg J; Isaias IU
    Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple linear brainstem MRI measurements in the differential diagnosis of progressive supranuclear palsy from the parkinsonian variant of multiple system atrophy.
    Constantinides VC; Paraskevas GP; Stamboulis E; Kapaki E
    Neurol Sci; 2018 Feb; 39(2):359-364. PubMed ID: 29196955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Molecular Imaging in Atypical Parkinsonism.
    Xu Z; Arbizu J; Pavese N
    Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Imaging in Atypical Parkinsonism.
    Heim B; Krismer F; Seppi K
    Int Rev Neurobiol; 2018; 142():67-148. PubMed ID: 30409261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism.
    Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stamboulis E; Kapaki E
    AJNR Am J Neuroradiol; 2018 Jun; 39(6):1047-1051. PubMed ID: 29622555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.
    Zanigni S; Evangelisti S; Testa C; Manners DN; Calandra-Buonaura G; Guarino M; Gabellini A; Gramegna LL; Giannini G; Sambati L; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2017 Jun; 39():44-51. PubMed ID: 28291592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain perfusion differences in parkinsonian disorders.
    Kimura N; Hanaki S; Masuda T; Hanaoka T; Hazama Y; Okazaki T; Arakawa R; Kumamoto T
    Mov Disord; 2011 Dec; 26(14):2530-7. PubMed ID: 21830234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manual MRI morphometry in Parkinsonian syndromes.
    Möller L; Kassubek J; Südmeyer M; Hilker R; Hattingen E; Egger K; Amtage F; Pinkhardt EH; Respondek G; Stamelou M; Möller F; Schnitzler A; Oertel WH; Knake S; Huppertz HJ; Höglinger GU
    Mov Disord; 2017 May; 32(5):778-782. PubMed ID: 28150443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowing of Frontal β Oscillations in Atypical Parkinsonism.
    Krösche M; Kannenberg S; Butz M; Hartmann CJ; Florin E; Schnitzler A; Hirschmann J
    Mov Disord; 2023 May; 38(5):806-817. PubMed ID: 37208967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal metabolic networks in atypical parkinsonism.
    Eckert T; Tang C; Ma Y; Brown N; Lin T; Frucht S; Feigin A; Eidelberg D
    Mov Disord; 2008 Apr; 23(5):727-33. PubMed ID: 18186116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Ito K; Shimoji K; Nakagawa M; Ozawa Y; Shimohira M; Ogawa M; Morimoto S; Aiba I; Matsukawa N; Shibamoto Y
    Magn Reson Med Sci; 2017 Jan; 16(1):16-22. PubMed ID: 27001391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic mimics of the non-genetic atypical parkinsonian disorders - the 'atypical' atypical.
    Giagkou N; Bhatia KP; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():327-351. PubMed ID: 31779819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism.
    Sugiyama A; Sato N; Kimura Y; Ota M; Maekawa T; Sone D; Enokizono M; Murata M; Matsuda H; Kuwabara S
    Parkinsonism Relat Disord; 2018 Mar; 48():10-16. PubMed ID: 29279191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI Signs of Parkinson's Disease and Atypical Parkinsonism.
    Aludin S; Schmill LA
    Rofo; 2021 Dec; 193(12):1403-1410. PubMed ID: 34034347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.